Sara Kozma

Title: The Innovative Contributions of Sara Kozma

Introduction

Sara Kozma is a prominent inventor based in Hesingue, France. She has made significant contributions to the field of biotechnology, particularly through her work on p70 S6 kinase. With a total of 2 patents, her inventions have advanced the understanding of kinase activity in various organisms.

Latest Patents

Sara's latest patents focus on Drosophila melanogaster p70 S6 kinase. The first patent provides p70, along with nucleic acids encoding this kinase. The sequences of p70 and the gene encoding it are represented in SEQ ID No. 2 and 1, respectively. This invention also includes mutated forms of p70, such as constitutively active and dominant negative forms, which are useful for studying p70 activity. Additionally, the invention offers expression systems that produce p70 in Drosophila and other organisms, facilitating the study of its activity.

The second patent similarly addresses Drosophila melanogaster p70 S6 kinase, providing the same essential components and applications as the first. This consistency in her work highlights the importance of p70 in biological research and its potential applications in various fields.

Career Highlights

Sara Kozma is currently associated with Novartis AG, a leading global healthcare company. Her role at Novartis allows her to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Sara has worked alongside notable colleagues, including Mary Stewart and George Thomas. Their combined expertise fosters an environment of innovation and discovery.

Conclusion

Sara Kozma's contributions to the field of biotechnology through her patents on p70 S6 kinase demonstrate her commitment to advancing scientific knowledge. Her work not only enhances our understanding of kinase activity but also paves the way for future research and applications in various biological contexts.